Drug and Gene Delivery Systems Market is Anticipated to Register 6% CAGR through 2025
The global drug and gene delivery systems market is expanding due to emerging, new and advanced technologies and increasing demand for targeted drug delivery at a low dosing frequency. Rise in R&D investments and increase in the demand for self-administration and home health care devices are some other factors driving the global market. However, high cost of the treatment and increase in drug recalls are some of the major restraints for the global drug and gene delivery systems market. North America and Europe are projected to dominate the global drug and gene delivery systems market in the next few years, owing to increase in manufacturers’ focus on business expansion in these regions. Players are continuously developing advanced drugs as well as delivery systems for drugs and genes and entering into distribution agreements to strengthen their foothold in the market in North America and Europe. Growing adoption of technologically advanced products manufactured by local manufacturers such as Intas Pharmaceuticals Ltd. is likely to drive the drug and gene delivery systems market in Asia Pacific during the forecast period. The market in the region is expected to register a CAGR of over 7% from 2017 to 2025.
Request A Sample Of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26135
Targeted Drug Delivery Segment dominates Market, followed by Polymeric Drug Delivery Segment
The report offers detailed segmentation of the global drug and gene delivery systems market, which is based on delivery system, route of administration, and application. Based on delivery system, the market has been segmented into drug delivery systems and gene delivery systems. Among drug delivery systems, the targeted drug delivery sub-segment is poised to account for a leading market share from 2017 to 2025. Factors responsible for the major share held by the sub-segment include increased demand for a rapid and accurate therapeutic action with less side-effects. The targeted drug delivery sub-segment is likely to register a higher growth rate in terms of value during the forecast period, owing to continuous innovations in product technologies by major market players. Among gene delivery systems, the viral gene delivery sub-segment is projected to account for a major market share from 2017 to 2025, due to factors such as increased incidence of genetic disorders with a different pattern of inheritance. The sub-segment is likely to register a higher growth rate in terms of value during the forecast period.
Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26135
Oncology and CNS: Top Two Application Areas of Drug and Gene Delivery Systems
Among applications, the oncology segment is projected to hold a dominant share of the global drug and gene delivery systems market during the forecast period. It is likely to expand at a high CAGR from 2017 to 2025. Major factors responsible for the dominance of this segment are continuous innovations in drug and gene delivery systems and wide product portfolio of major as well as local manufacturers. For instance, in February 2018, Becton, Dickinson and Company launched PAXgene, a circulating cell-free DNA blood collection tube for pre-natal cancer testing application. Such continuous launches of new products and significantly expanding base of cancer patients in developed as well as developing countries are likely to drive the oncology segment between 2017 and 2025. According to JAMA oncology, in the year 2015, around 17.5 million new cancer cases were detected globally and around 8.8 million deaths were caused by cancer, which means nearly one in every six deaths was caused by cancer. The urology segment of the drug delivery systems market is projected to expand at a CAGR of above 6%, while the urology segment of the gene delivery systems market is estimated to expand at a CAGR of above 7% during the forecast period. CNS and diabetes segments collectively accounted for more than 31.0% share of the global drug and gene delivery systems market in 2016, in terms of value.
Injectable and Oral: Top Two Routes of Administration of Drug and Gene Delivery Systems
Among routes of administration, the injectable segment is projected to hold a dominant share of the global drug and gene delivery systems market by the end of the forecast period and is likely to expand at a high CAGR from 2017 to 2025. Technological advancements and advantages offered by the injectable route in terms of drug delivery are a few major factors driving the segment. For instance, in 2017, Somatuline Depot (lanreotide) injectable formulation was approved by the U.S. FDA for the treatment of acromegaly. Some other drivers include continuous innovations in drug and gene delivery systems and wide product portfolio of major as well as local manufacturers. For instance, in September 2017, Baxter International Inc. launched DeviceVue, an advanced asset-tracking system for Sigma Spectrum Infusion System. The inhalation segment of the drug delivery systems market is projected to expand at a CAGR of above 6%, while the inhalation segment of the gene delivery systems market is likely to expand at a CAGR of above 7% during the forecast period.
Request For Discount On This Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=26135
Growth of Asia Pacific Drug and Gene Delivery Systems Market likely to be hinged at China, Japan
In terms of value, North America led the global drug and gene delivery systems market in 2016. Increased demand for drug and gene products and risen prevalence of chronic and acute diseases such as cancer and diabetes among people in the U.S. are factors responsible for the major share held by North America in the global market. However, high cost of treatment and increase in drug recalls are likely to hamper the market in the region between 2017 and 2025. Healthcare spending in emerging markets such as China and India is rising, which is fuelling the Asia Pacific drug and gene delivery systems market. Economic growth of countries in Latin America such as Brazil is augmenting the health care expenditure in the region, through rise in private health insurance and entry of international drug manufacturers and health care providers in the region. This factor is likely to propel the Latin America drug and gene delivery systems market from 2017 to 2025.
Highly Consolidated Market with Top Players accounting for a Major Share
The report also provides profiles of leading players operating in the global drug and gene delivery systems market including Novartis AG, Amgen Inc., Becton, Dickinson and Company (BD), Oxford BioMedica plc, and SIBIONO. These players offer a wide range of products. For instance, Novartis AG offers both drug delivery systems and gene delivery systems. Becton, Dickinson and Company (BD) provides drug delivery systems for a wide range of diseases. Amgen Inc. offers advanced drug delivery products as well as gene delivery products. Expansion of the portfolio of drug and gene delivery products through partnerships to improve efficacy and quality of products is a growing trend currently observed in the global drug and gene delivery systems market. For instance, in January 2017, 3M Drug Delivery System collaborated with Panacea Pharmaceuticals, a therapeutic drug development company, for the delivery of an investigational therapeutic cancer vaccine. Other prominent players operating in the global drug and gene delivery systems market include Epeius Biotechnologies Corporation, Boston Scientific Corporation, Human Stem Cells Institute, Baxter International, Inc., and AstraZeneca plc
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug and Gene Delivery Systems Market is Anticipated to Register 6% CAGR through 2025 here
News-ID: 1157209 • Views: 115
More Releases from Transparency Market Research
Market Intelligence Report on Calcite Market, 2018-2028
Sales of calcite have witnessed utter proliferation in recent time, in line with the growing demand from paper and pulp sector wherein calcite is highly adopted as a coating and filler material. According to Transparency Market Research analysis, global calcite market is anticipated to register 4.7% CAGR during the study period 2018–2028. The TMR report opines that demand for calcite is highly driven by its significant properties that are paving way
Pearlescent Pigments Market Intelligence Report Offers Growth Prospects
The demand within the global pearlescent pigment market is slated to rise as new creative avenues emerge in the art and craft industry. Several artists have increased the consumption of pearlescent pigments, mainly due to the aesthetic value of these pigments in art forms. The use of these pigments can majorly be attributed to the gloss and shine imparted by these pigments to the design or craft. These pigments exhibit
Aragonite Market to Witness Steady Growth During the Forecast Period 2018-2026
Global Aragonite Market: Overview Aragonite is a carbonate mineral having an orthorhombic crystal system, and very closely resembles calcite. It is considered as the purest form of calcium carbonate. The mineral has garnered wide popularity as gemstone in various parts of the world and has promising healing properties with energy enhancing powers. Aragonite contains traces of magnesium and sand inclusion but rich in calcium carbonate, and is alkaline in nature. It
OEM Insulation Market Growth, Trends and Value Chain 2019-2027 by TMR
OEM Insulation Market – Overview OEM means Original Equipment Manufacturer that indicates to a company that produces a part or a subsystem of a product that is being used by another organization. Thermal insulation or simply insulation allows the product to cut down the heat gain or loss at the minimum by creating a barrier between the surfaces at the varying temperatures. There are wide range of applications and end-use verticals
More Releases for CAGR
Catalase Market : Research Observes Strong CAGR Development
The "Global Catalase Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024", report intends to offer a resourceful means to assess the Catalase Market and entails the all-inclusive analysis and upfront statistics with regards to the market. This new report is committed fulfilling the requirements of the clients by giving them thorough insights into the market. The Catalase Market report, titled Catalase Market, is expansive research
Citicoline Market | CAGR of 14.4%
The global Citicoline Market 2020 Report provides fine intelligence that helps market players to compete well against the tough competition on the basis of growth, sales and other various important factors. The research report lays stress on key growth opportunities and market trends apart from important market dynamics including market drivers and challenges. With the help of this report, involved parties can equip themselves to adapt along with the changes
Footwear Market : Research Observes Strong CAGR Development
The "Global Footwear Market Set for Rapid Growth, to Reach Around USD 320.44 Billion by 2023", report intends to offer a resourceful means to assess the Footwear Market and entails the all-inclusive analysis and upfront statistics with regards to the market. This new report is committed fulfilling the requirements of the clients by giving them thorough insights into the market. The Footwear Market report, titled Footwear Market, is expansive research
Xanthates Market CAGR to Grow at 4.7%
Persistence Market Research in its latest report projects that the global xanthates market will grow at a CAGR of 6.1% over the forecast period (2017-2025). Owing to Xanthates’ excellent mineral ore processing capabilities, its global sales have witnessed a significant rise in recent years. Mining complexity and declining ore quality have led to a major increase in demand for specialty chemicals to process ores. Towards the end of 2025, around
Global Serious Games Market Show 19.2% CAGR
A new report added by Allied Market Research, forecast that the global serious games market was valued at $2,731 million in 2016, and is projected to reach $9,167 million by 2023, growing at a CAGR of 19.2% from 2017 to 2023. The consumers segment is anticipated to grow at the highest rate during the forecast period. Asia-Pacific generated the highest revenue in the global serious games market in 2016 due to
Bioinsecticides market expecting CAGR 5.4%
Reports And Markets Publish a New Market Research Report On –"Bioinsecticides market- Growth, Trends, Forecast for the period (2017 - 2022)" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/1071910-global-bioinsecticides-market-growth-trends-forecast-for-the-period-2017-2022 Pesticides constitute the largest category within the market for crop protection chemicals, with biopesticides accounting for a comparatively minute share. Global consumption of synthetic insecticides is projected to reach 833.32 thousand tons by volume and USD 19.6 billion by value by 2020